Younger kidney cancer patients on VEGF inhibitors at elevated risk for hypertension

by

Hypertension during treatment is common among adolescents and young adults (AYAs) being treated with vascular endothelial growth factor (VEGF) inhibitors for renal cancer, according to a study published online July 5 in the Journal of the National Comprehensive Cancer Network.

Leave A Comment

Your email address will not be published. Required fields are marked *